UCB (OTCMKTS:UCBJY) Share Price Passes Above 50-Day Moving Average – Should You Sell?

by · The Cerbat Gem

UCB SA (OTCMKTS:UCBJY – Get Free Report)’s share price crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $92.02 and traded as high as $98.33. UCB shares last traded at $98.04, with a volume of 108,542 shares trading hands.

UCB Stock Performance

The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.78 and a current ratio of 1.19. The company’s 50 day moving average is $92.02 and its 200-day moving average is $80.32.

About UCB

(Get Free Report)

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies.

Featured Articles